Psychotherapy and Psychosomatics
June 19, 2026
Judith Rohde, Tyler M Moore, Kathryn Walker et al.
Ketamine combined with psychotherapy has shown promise in treating posttraumatic stress disorder (PTSD), but predictors of clinical benefit remain unclear. In this systematic review and individual participant data meta-analysis (IPDMA), we examined patient- and treatment-level predictors of PTSD symptom change after combined treatment. Eligible studies combined ketamine with psychotherapy in...
Human Arenas
April 25, 2026
Shannon Dames, Grace Scharf, Vivian W. L. Tsang et al.
Ritual is a cultural-psychological technology that facilitates transitions by establishing safety, trust, and shared meaning. In psychedelic therapy, ritual remains underdeveloped despite the heightened vulnerability and suggestibility inherent in non-ordinary states. Without clear frameworks, ritual applications can become prescriptive or ethically problematic—particularly when elements are...
Frontiers in Public Health
January 29, 2026
Vivian W. L. Tsang, Camille Roney, Pamela Kryskow et al.
Psilocybin-assisted therapy (PAT) is an emerging intervention that combines the administration of psilocybin with structured psychological support to address profound psychological, emotional, and existential distress. Central to this model is the recognition that many forms of suffering-particularly at end of life-are relational in nature and require relational forms of healing. It is our...
Psychedelics
January 18, 2026
Vivian W. L. Tsang, Tanner Jones, Sally Tsoi et al.
As psychedelic use grows in popularity, it is important to understand usage patterns and clinical outcomes associated with their consumption. This study explored patterns of psychedelic use among college-aged individuals, focusing on dosing behaviors, usage intentions, and the impact of childhood trauma. Using a self-administered online survey, participants reported on their demographics,...
Journal of Psychiatric Research
November 1, 2025
Vivian W. L. Tsang, Brendan Tao, Raimey Olthuis et al.
The Apollo wearable device (wrist or ankle) is an investigational device which provides touch therapy with silent vibrations that may help individuals reduce the symptoms of stress such as difficulty breathing, sleeping or focusing on tasks. Positive feedback from a mental health treatment program that uses ketamine-assisted therapy as a treatment adjunct inspired researchers to assess the...
Journal of Occupational and Environmental Medicine
October 17, 2025
Vivian W. L. Tsang, Megan Kennedy, Tarun Walia et al.
1 citation
OBJECTIVE: Many first responders deal with mental health challenges due to significant work-related stress. Ketamine-assisted therapy (KAT) has been shown to alleviate the symptoms and improve the lives of those living with PTSD. This qualitative case study explores the impacts of KAT on the firefighters beyond the initial alleviation of their PTSD symptoms. METHODS: Six firefighters who were...
Frontiers in Psychiatry
September 22, 2025
Shannon Dames, Pamela Kryskow, Vivian W. L. Tsang et al.
3 citations
RTT-KaT offers a structured, scalable, evidence-informed, and culturally responsive model that bridges clinical safety with both Western and Indigenous knowledge systems. A longitudinal follow-up study is currently underway to evaluate long-term impact and guide future implementations.
Journal of Psychedelic Studies
October 29, 2024
Pamela Kryskow, Paul Stamets, Joseph T. la Torre et al.
4 citations
Abstract Interest in psychedelic research in the West is surging, however, clinical trials have almost exclusively studied synthetic compounds such as MDMA, ketamine, DMT, LSD, ibogaine, and psilocybin. To date, few clinical trials have utilized whole mushroom/plant material like Psilocybe mushrooms, Iboga, or Ayahuasca. Individuals participating in the Roots To Thrive Psilocybin-Assisted...
Psychedelic Med (New Rochelle)
September 4, 2024
Shannon Dames, Crosbie Watler, Pamela Kryskow et al.
4 citations
Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence.
European Psychiatry
March 1, 2023
Saundarai Bhanot, Michelle Cq Lin, S. Bains et al.
3 citations
Introduction Psilocybin is a naturally occurring psychedelic compound whose effects have been seen in studies for treatment of depression, anxiety and pain management. Given its structural similarities to 5-hydroxytryptamine, a monoamine controlling brain modulation of pain input, preliminary studies sought to test serotonergic interactions of psilocybin with headaches. Objectives Explore...
Therapeutic Advances in Psychopharmacology
2023
Vivian W. L. Tsang, Brendan Tao, Shannon Dames et al.
19 citations
In the last few years, ketamine is becoming increasingly common in the treatment of mental health conditions, but there is a lack of safety data informing intramuscular and sublingual dosing in a community-focused group psychotherapy setting. The Roots To Thrive ketamine-assisted therapy (RTT-KaT) program is a unique 12-week RTT-KaT program with 12 community of practice (a form of group...